Even though it is widely accepted that rIFN-β-induced IL-10 mediates the suppressive effect of rIFN-β in EAE (and MS), to the best of our knowledge, our data shown here directly validate this assumption for the first time. Here, IL10 is linked to myeloid sarcoma.